H1 and Novo Nordisk partner to accelerate clinical trials with AI
The deal gives H1 rights to StudyHub, Novo Nordisk's in-house clinical development platform, and signals a broader shift in how pharma is approaching trial design
UK sees 17% surge in medical device trials as brain tech takes off
Regulators fast-track approvals while neurotechnology studies double, putting Britain at center of global health innovation race
Clinical Research IO raises $1.6M for its clinical trials platform
The company will use the funds to develop its sales and vendor partnerships.